VYGR icon

Voyager Therapeutics
VYGR

Overview Fund Activity

75 hedge funds and large institutions have $233M invested in Voyager Therapeutics in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 7 closing their positions.

Holders
75
Holders Change
+23
Holders Change %
+44.23%
% of All Funds
1.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
26
Reduced
12
Closed
7
Calls
$3.61M
Puts
$21K
Net Calls
+$3.59M
Net Calls Change
+$3.63M

Top Buyers

1
Wells Fargo
1
Wells Fargo
California
$7.77M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$14.4M
3
EAM
3
Eventide Asset Management
Massachusetts
$11.6M
4
Citadel Advisors
4
Citadel Advisors
Florida
$5.16M
5
BBA
5
Baker Bros. Advisors
New York
$4.88M

Top Sellers

1
BCPEM
1
Bain Capital Public Equity Management
Massachusetts
$0
2
PHS
2
PFM Health Sciences
California
$8.19M
3
DCM
3
DAFNA Capital Management
California
$2.41M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$0
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$76.1M
Name Market Value Shares Shares
Change 		Shares
Change %
BCPEM
76
Bain Capital Public Equity Management
Massachusetts
– – -1,176,470 Closed
T. Rowe Price Associates
77
T. Rowe Price Associates
Maryland
– – -150,384 Closed
Bessemer Group
78
Bessemer Group
New Jersey
– – -44,828 Closed
HP
79
Harbourvest Partners
Massachusetts
– – -44,606 Closed
HTC
80
Hershey Trust Company
Pennsylvania
– – -14,394 Closed
GEA
81
Glen Eagle Advisors
New Jersey
– – -500 Closed
Citigroup
82
Citigroup
New York
– – -97 Closed
BFM
83
Boothbay Fund Management
New York
– – – –
1 2 3
4